ABSTRACT
Rabbit syndrome is a perioral involuntary, extrapyramidal movement distrubance associated with prolong use of neuroleptics (Villeneure, 1972; Berger and Roxroth, 1980) . The distrubance involves the oral and masticatory musculature except for the tongue; it is similar in appearance to the movements of rabbit's mouth. Quickly alternating, regular movements along a vertical axis occur at frequency of approximately 5 Hz. There is an associated popping like sound produced as the lips rapidly separate. Differential diagnosis between tardive dyskinesia and rabbit syndrome is often confused; tardive dyskinesis also can invlove orofacial musculature but is manifested by chewing like movements that include writhing or thrusting tongue motion. Differentiation between the two conditions is made clinically. Abnormal movements in tardive dyskinesia are significantly slower and less regular than in rabbit syndrome. Although both disorders are sequelae of long-term neuroleptic treatment (Jus etal., 1979) , rabbit syndrome responds to antiparkinsonian medication, while tardive dyskinesia is often exacerbated by such therapy.
Rabbit syndrome was first described by Villeneuve in 1972. The condition is reported to be rare (Todd et al., 1S83) .
To the best of author's knowledge no such case is reported or published from India. A case of rabbit syndrome is described.
CASE REPORT
Ms A, 46 years old medical graduate, had undergone treatment for psychosis from psychiatrists. She was hospitalised several times. Results of physical examination and CT scan were normal. She was diagnosed to be suffering from chronic schizophrenia with acute exacerbations off and on. She was on oral flupenthixol for last one year without any antiparkinsonian medication. Earlier she was given other neuroleptics like haloperidol, trifluoperazine etc.
She was noticed to have rapid involuntary orofacial movements without lingual involvement. Her jaw moved alternately up and down. The movements decreased in severity with voluntary activity including talking. No other extrapyramidal signs were present. A diagnosis of rabbit syndrome was made. Oral flupenthixol was stopped and trihexyphendyl HCI2 mg three times a day was started. Within 4 days, she responded to the treatment and in a fortnight, all the movements stopped.
Flupenthixol was reintroduced later along with trihexyphenydil HCI.No abnormal movements were noticed later.
DISCUSSION
The rabbit syndrome has been reported primarily in middle-aged and elderly patients (Jus et al., 1979) . It occurs with a variety of neuroleptics. Following neuroleptics have been reported to produce rabbit syndrome-haloperidol, fluphenazine, perphenezine, trifluoperazine, thioproperazine and mesoridazine (Sovner and Mascio, 1977; Todd et al., 1983; Yassa and Lai, 1986) .
Anticholinergic agents in general aggravate or uncover tardive dyskinesia, although in some cases no effect or occasionally amelioration occurs (Gerlach et al., 1974) . In contrast, anticholinergics consistently improve the rabbit syndrome, as was noted in the present case.
The rabbit syndrome is uncommon in patients chronically treated with neuroleptics. Yassa and Lai (1986) reported the incidence to be 2.3%. The reasons for the apparent infrequency of rabbit syndrome may be related to the following factors: (1) many patients receive concomitant antiparkinsonian medication; (2) it is not a well-known side effect and may be mistaken for tardive dyskinesia; (3) in some patients the syndrome is mild and only elicited by a distracting task and (4) most scales used to evaluate extrapyramidal symptoms do not include an item for the rabbit syndrome (an exception is the Simpson Rating Scale for Tardive Dyskinesia). Failure to recognise the rabbit syndrome and concern over aggravating tardive dyskinesia may lead to withholding higly effective treatment with anticholinergic agents or unecessarily reducing the dose of required neuroleptic. 
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